Do we need ‘new’ omega-3 polyunsaturated fatty acids formulations?

Omega-3 Carboxylic Acids (Epanova®): A Review of Its Use in Patients with Severe Hypertriglyceridemia

(2014) Hannah A. Blair et al.   American Journal of Cardiovascular Drugs

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials

(2013) Manuela Casula et al.   ATHEROSCLEROSIS SUPPLEMENTS

State of the art paper Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects

(2012) Arrigo F.G. Cicero et al.   Archives of Medical Science

Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: A meta-analysis of randomized controlled trials

(2012) Ling-gen Gao et al.   ATHEROSCLEROSIS

Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies

(2012) Yunping Zhou et al.   BRITISH JOURNAL OF NUTRITION

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

(2012) Evangelos C. Rizos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation

(2010) Eli I. Lev et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Omega-3 Polyunsaturated Fatty Acids: Their Potential Role in Blood Pressure Prevention and Management

(2009) Arrigo Cicero et al.   Current Vascular Pharmacology